1-4 of 4
Michael A. Linden, MD, PhD
Close
Sort by
Journal Articles

Romiplostim Improves Platelet Recovery after UCB Transplant

Georgios E. Christakopoulos, MD, Todd E. DeFor, MS, Stefanie M Hage, RN, John E. Wagner, MD, Michael A. Linden, MD PhD, Claudio G Brunstein, MD PhD, Nelli Bejanyan, MD, Michael R Verneris, MD, Angela R. Smith, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 1979.
https://doi.org/10.1182/blood-2019-125424
Published: 2019
Journal Articles

The Effect of Measurable Residual Disease at the Time of Allogeneic Hematopoietic Cell Transplantation on Outcomes in Patients with Acute Myeloid Leukemia: A Meta-Analysis

Sarah A. Buckley, MD, Brent L. Wood, MD PhD, Megan Othus, PhD, Christopher S. Hourigan, MD PhD, Celalettin Ustun, MD, Michael A. Linden, MD PhD, Todd E. DeFor, MS, Michele Malagola, MD PhD, Christopher G. Kanakry, MD, Bernd Gruhn, MD, Beth Devine, PhD PharmD, Roland B. Walter, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2842.
https://doi.org/10.1182/blood.V128.22.2842.2842
Published: 2016
Journal Articles

Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation

Fatima Khan, MBBS, Michael A. Linden, MD, PhD, Nicole D. Zantek, M.D., Ph.D., Gregory M Vercellotti
Journal: Blood
Blood (2013) 122 (21): 5495.
https://doi.org/10.1182/blood.V122.21.5495.5495
Published: 2013
Journal Articles

Autologous and Allogeneic Donor Transplantation for Mantle Cell Lymphoma in Rituximab Era: Impact of Pre-Transplant Burden On Survival.

Erik A Magnusson, MS, Qing Cao, MS, Michael A. Linden, MD, PhD, Linda J Burns, MD, Daniel J. Weisdorf, MD, Veronika Bachanova, MD
Journal: Blood
Blood (2012) 120 (21): 3092.
https://doi.org/10.1182/blood.V120.21.3092.3092
Published: 2012